Ura Kazuya, Goubaru Yumi, Motoya Misato, Ishii Hidehiro
Department of General Internal Medicine, Saiseikai Futsukaichi Hospital, Fukuoka, Japan.
Department of Diabetology, Saiseikai Futsukaichi Hospital, Fukuoka, Japan.
Case Rep Infect Dis. 2023 May 30;2023:6684783. doi: 10.1155/2023/6684783. eCollection 2023.
Persistent fever due to coronavirus disease 2019 (COVID-19) is a considerable issue for patients and physicians that requires a broad differential diagnosis and evaluation of complications. Coinfections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and various respiratory viruses have also been reported. In severe cases of COVID-19, cytomegalovirus (CMV) reactivation or CMV coinfection with SARS-CoV-2 has been reported in association with critical illnesses and immunosuppressive therapy; however, in mild COVID-19 cases, CMV coinfection with SARS-CoV-2 has been reported only in severely immunocompromised patients, and its incidence and clinical importance remain unclear. Herein, we report a rare case of coinfection with SARS-CoV-2 and CMV in a patient with mild COVID-19 and untreated diabetes mellitus, which led to persistent fever for approximately 4 weeks. CMV coinfection should be considered in patients with COVID-19 who exhibit persistent fever.
2019冠状病毒病(COVID-19)所致的持续发热对患者和医生来说是一个相当重要的问题,需要进行广泛的鉴别诊断和并发症评估。也有报告称严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与多种呼吸道病毒合并感染。在COVID-19重症病例中,已报告巨细胞病毒(CMV)激活或CMV与SARS-CoV-2合并感染与危重症及免疫抑制治疗有关;然而,在轻度COVID-19病例中,仅在严重免疫功能低下的患者中报告了CMV与SARS-CoV-2合并感染,其发生率和临床重要性尚不清楚。在此,我们报告一例轻度COVID-19且未治疗的糖尿病患者发生SARS-CoV-2与CMV合并感染的罕见病例,该病例导致持续发热约4周。对于出现持续发热的COVID-19患者,应考虑CMV合并感染。